Latest Breaking News On - Abm 1310 - Page 1 : comparemela.com

The FDA has granted fast track designation to ABM-1310 for the treatment of patients with glioblastoma harboring BRAF V600E mutations.

United statesZane yangResponse assessmentAbm 1310Braf v600eFast track designation